Medtronic launches pacemaker that links patients smartphone and tablet


Medical device maker Medtronic launched Azure™ pacemaker with BlueSync™ technology – a pacemaker that can communicate directly with patients’ smartphones and tablets. It is the latest addition to Medtronic’s Cardiac Rhythm & Heart Failure portfolio in India. The new device is said to be designed to accurately detect and reduce the likelihood of atrial fibrillation.


Talking about the features of the new device the company statement indicated Azure Medtronic-exclusive BlueSync technology, enables automatic, secure wireless communication via Bluetooth Low Energy and remote monitoring via the Medtronic CareLink™ Network, providing more timely alerts of clinically relevant patient events that can be reviewed by a clinician at any time. Security controls implemented and validated on BlueSync enabled devices to include access restrictions to protect the integrity of device functionality and end-to-end encryption to protect patient data.

Also read: Medtronic unveils cordless ultrasonic surgery dissection system

“The device also offers improved longevity (up to 13.7 years), so patients potentially need fewer device replacements and allow patients to have MRI (magnetic resonance imaging) scans in either 1.5 or 3 Tesla (T) machines. The new device is said to be designed to accurately detect and reduce the likelihood of atrial fibrillation,” the statement added.


Atrial fibrillation (AF) is an irregular, rapid heart rate that may cause symptoms like heart palpitations, fatigue, and shortness of breath. AF occurs when the upper chambers of the heart (atria) beat out of rhythm. As a result, blood is not pumped efficiently to the rest of the body, causing an unusually fast heart rate, quivering, or thumping sensations in the heart.

“The launch of Azure, our most advanced pacemaker, is a testament to our commitment toward re-imagining innovation and delivering improved outcomes while reducing the burden on healthcare systems. The pacemaker communicates directly and securely with the MyCareLink Heart™ mobile app – an important advancement in the ongoing quest to constantly monitor patient condition remotely. Remote monitoring of heart conditions allows patients to receive expert medical advice from their physician while at home or traveling instead of making multiple trips to the hospital. It is a boon for heart patients and caregivers, especially in situations such as the COVID-19 pandemic, providing peace of mind and freedom,” said Madan Krishnan, Vice President, India Medtronic Pvt Ltd and Minimally Invasive Therapies Group APAC.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top